Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
March 3, 2026
Impact of IMWG Frailty and Nutritional Biomarkers on Outcomes in MM Pts Undergoing ASCT
DU
Dilek Uzun
AZ
Angela Qixin Zhang
RA
Rachel Austin
See all
Key Points
Outcomes are significantly influenced by frailty and nutritional biomarkers in multiple myeloma patients undergoing ASCT.
Key evidence shows that patients with higher frailty scores experienced worse outcomes compared to less frail patients.
Observational analysis assessed the relationship between frailty, nutritional markers, and treatment outcomes in a multiple myeloma cohort.
Implications highlight the need for nutritional support and frailty assessment to improve treatment strategies in this population.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Uzun et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760d2c6e9836116a2def7
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.627
Impact des biomarqueurs de fragilité et nutritionnels selon l'IMWG sur les résultats chez les patients atteints de MM subissant un ASCT | Synapse